Family Medicine · Glendale, CA
NPI
1447358981
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
445 W Broadway
Glendale, CA, 91204
Phone (818) 241-2103
Groups this clinician bills Medicare through
Medicare paid, 2024
$437K
7,066 services
Medicare patients, 2024
764
Average age 77
Drug cost, 2024
$4.9M
48,936 prescriptions
Company payments, 2025
$1,393
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anait Galfaian was code 99213 (office e&m - established), 1,987 times for 474 patients. In total Anait Galfaian billed 7,066 services in 42 codes, and Medicare paid $437K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,987 | 474 | $68.14 | $135K |
| 99232 Hospital E&M - Subsequent | Facility | 1,428 | 188 | $59.02 | $84K |
| 99309 SNF E&M | Facility | 623 | 97 | $82.20 | $51K |
| 36415 Venipuncture Blood Collection | Office | 622 | 380 | $8.65 | $5,380 |
| 99212 Office E&M - Established | Office | 536 | 265 | $43.23 | $23K |
| 99223 Hospital E&M - Initial | Facility | 264 | 195 | $129.68 | $34K |
| 99214 Office E&M - Established | Office | 234 | 200 | $95.84 | $22K |
| 93000 Electrocardiogram | Office | 219 | 190 | $10.89 | $2,385 |
| 99239 Hospital Discharge Management | Facility | 187 | 145 | $86.55 | $16K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 174 | 174 | $127.51 | $22K |
| 96372 Injection Administration | Office | 117 | 56 | $10.85 | $1,269 |
| 99497 Care Management/Coordination | Office | 89 | 89 | $63.13 | $5,618 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 76 | 36 | $0.93 | $70.4 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 60 | 51 | $177.16 | $11K |
| 99305 SNF E&M | Facility | 48 | 44 | $101.17 | $4,856 |
By year: 2022 $421K for 6,555 services; 2023 $468K for 7,135 services; 2024 $437K for 7,066 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 622 | 380 | $8.65 | $5,380 |
| Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens | 28 | 28 | $17.40 | $487 |
| Q0112 All potassium hydroxide (koh) preparations | 28 | 28 | $5.71 | $160 |
Medicare prescription drug claims, 2024
In 2024, the drug Anait Galfaian prescribed most often to Medicare patients was Montelukast Sodium, with 1,978 prescriptions and refills. In total Anait Galfaian wrote 48,936 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,978 | 2,095 | 257 | $7,836 |
| Amlodipine Besylate Generic | 1,720 | 1,903 | 217 | $2,792 |
| Icosapent Ethyl Generic | 1,680 | 1,734 | 242 | $269K |
| Rosuvastatin Calcium Generic | 1,426 | 1,615 | 182 | $4,958 |
| Diclofenac Sodium Generic | 1,358 | 1,410 | 173 | $604K |
| Atorvastatin Calcium Generic | 1,188 | 1,260 | 149 | $3,984 |
| Levothyroxine Sodium Generic | 1,142 | 1,260 | 122 | $5,034 |
| Gabapentin Generic | 1,113 | 1,156 | 130 | $4,327 |
| Famotidine Generic | 884 | 929 | 118 | $2,506 |
| Furosemide Generic | 835 | 873 | 105 | $1,927 |
| Metoprolol Tartrate Generic | 808 | 887 | 105 | $2,052 |
| Ibuprofen Generic | 807 | 831 | 118 | $4,210 |
| Pantoprazole Sodium Generic | 791 | 856 | 112 | $3,021 |
| Vascepa Icosapent Ethyl | 735 | 781 | 97 | $208K |
| Buspirone Hcl Generic | 730 | 736 | 97 | $2,306 |
Brand drugs: 8,073 claims; generic drugs: 40,200 claims; opioid claims: 138.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anait Galfaian $1,393 ($1,393 in general payments such as food, travel and fees) from 6 companies. The largest payer was Amgen Inc. with $1,069.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.